20
A. Grabulosa et al. / Journal of Molecular Catalysis A: Chemical 330 (2010) 18–25
These boranes can be converted into the free phosphine
2.9. Bis((o-trifluoromethylphenyl)tert-
butylmethylphosphine)palladiumdichloride,
12
by reaction with HBF4. (ortho-Trifluoromethylphenyl)(tert-
butyl)methylphosphineborane (262 mg, 1.0 mmol) was dissolved
in 10 mL of dichloromethane and the solution cooled to −30 ◦C.
HBF4·OMe2 (0.350 mL, 2.9 mmol) was added and the mixture
was allowed to warm to room temperature overnight. 31P NMR
spectroscopy indicated the total conversion to the phosphonium
salt (d = +20 ppm). The reaction mixture was treated with 30 mL of
previously degassed saturated aqueous solution of NaHCO3 and the
organic layer was extracted with dichloromethane under argon.
The combined organic extracts were dried with sodium sulfate
and filtered. Concentration to dryness under vacuum afforded the
desired product as a yellow/brown oil. Yield: 170 mg (68%).
(ortho-Trifluoromethylphenyl)tert-butylmethylphosphine
(55 mg, 0.220 mmol) was dissolved in dry degassed CH2Cl2 (2 mL).
[PdCl2(PhCN)2] (42 mg, 0.110 mmol) was added and the mix-
ture stirred at room temperature for 24 h. The solvent was then
reduced to near dryness and diethyl ether added resulting in
a yellow precipitate, which was filtered off and washed with
further diethyl ether to yield the title compound (45 mg, 73 mmol,
67% yield). The complex is present as a mixture of the rac and
meso isomers leading to two sets of signals in the ratio 1:2.5 by
19F NMR. Recrystallisation by slow diffusion of hexane into a
CH2Cl2solution of the product yielded crystals suitable for X-ray
crystallography.
2.7. n-Butyl(t-butyl)(o-trifluoromethylphenyl)phosphine-borane,
1H NMR (400 MHz; CD2Cl2): ı 7.79 (2H, m, ArH), 7.69 (2 H, m,
ArH), 7.49 (4H, m, ArH), 1.86 (3H, t app., J = 7.4 Hz, P-CH3 major iso-
mer), 1.85 (3H, t app., J = 7.4 Hz, P-CH3 minor isomer), 1.21 (9 H, t
app., J = 7.4 Hz, C(CH3)3 minor isomer), 1.20 (9 H, t app., J = 7.4 Hz,
C(CH3)3 major isomer). 1H{19F}NMR (400 MHz; CD2Cl2): ı 7.79
(1H, m, ArH), 7.69 (1 H, m, ArH), 7.49 (2H, m, ArH), 1.86 (3H, t
app., J = 7.4 Hz, P-CH3 major isomer), 1.85 (3H, t app., J = 7.4 Hz,
P-CH3 minor isomer), 1.21 (t app., J = 7.4 Hz, C(CH3)3 minor iso-
mer), 1.20 (t app., J = 7.4 Hz, C(CH3)3 major isomer). 1H{31P} NMR
(400 MHz; CD2Cl2): ı 7.79 (1H, m, ArH), 7.69 (1 H, m, ArH), 7.49
(2H, m, ArH), 1.86 (3H, s, P-CH3 major isomer), 1.85 (3H, s, P-CH3
minor isomer), 1.21 (s, C(CH3)3 minor isomer), 1.20 (s, C(CH3)3
10
The same procedure used in the preparation of 9 (Route A) was
followed, employing n-BuLi solution in hexanes instead of MeLi.
From t-butyl(o-trifluoromethylphenyl)chlorophosphine (927 mg,
3.45 mmol) and n-BuLi (2.9 mL of a 2.5 M solution, 7.25 mmol) the
title compound was obtained after chromatography as a colourless
oil with purity ranging from 95 to 99%. Yield: 313 mg (30%).
1H NMR (400 MHz, CDCl3): ı 8.27–8.21 (m, 1H), 7.85–7.82
(m, 2H), 7.64–7.52 (m, 2H), 2.36 (m, 1H), 1.92–1.83 (m, 1H),
1.81–1.69 (m, 1H), 1.45–1.37 (m, 2H), 1.31–1.25 (m, 1H), 1.13 (d,
9H, J = 13.8 Hz), 0.90 (t, 3H, J = 7.4 Hz), 1.80–0.10 (br, q, 3H, BH3).
1
major isomer).13C{ H} NMR (101 MHz; CD2Cl2): ı 134.7 (m, ArCH),
1
13C{ H}NMR- (101 MHz, CDCl3): ı 139.9 (d, CH, J = 18.0 Hz), 131.2
132.0 (m, ArC), 129.4 (m, ArCH), 129.2 (s, ArCH), 128.9 (m, ArC),
127.5 (m, ArCH), 123.5 (q, J = 275.5 Hz, CF3), 34.6 (t app., J = 11.1 Hz,
C(CH)3 major isomer), 34.4 (t app., J = 11.1 Hz, C(CH)3, minor iso-
mer), 26.8 (m, C(CH)3), 8.2 (m, P-CH3). 19F NMR (376 MHz; CD2Cl2):
ı −52.95 (t, J = 6.9 Hz, major isomer), −53.1 (t, J = 6.9 Hz, minor iso-
mer). 31P NMR (162 MHz; CD2Cl2): ı 27.4 (m). IR (cm−1), KBr, 3200,
3500, 2900–3000, 2200, 1300. MS ES+ 697.02 (M+Na). Calcd. for
C24H23Cl2F6P2Pd, C 42.78%, H 4.79%; found: C 42.65%, H 4.74%.
(CH), 131.1 (CH), 128.0 (t, CH, J = 7.9 Hz), 125.3 (m, CF3), 31.2 (d, C,
J = 38.9 Hz), 26.6 (s, CH2), 25.4 (d, CH2), 24.5 (d, CH2, J = 19.5 Hz), 20.9
1
(dd, CH3, J = 42.4 Hz, 5.9 Hz), 13.6 (s, CH3). 31P{ H}NMR (162 MHz,
1
CDCl3): ı +43.2 (d, J = 71.9 Hz). 19F{ H}NMR (376 MHz, CDCl3): ı
−56.0 (s). 11B NMR (128 MHz, CDCl3): ı −37.4 (m).
MS (ES+): 327 (M+Na+); HRMS calcd. for C15H25BF3NaP,
327.1637; found 327.1630.
2.10. Bis[n-butyl(t-butyl)(o-
trifluoromethylphenyl)phosphine]palladiumdichloride,
2.8. tert-Butylbis(o-(trifluoromethyl)phenyl)phosphine 11
13
A
stirred solution of ortho-bromobenzotrifluoride (8.49 g,
5.26 mL, 37.7 mmol) diethyl ether (40 mL) was cooled to −78 ◦C, and
n-butyllithium (15 mL as a 2.5 M solution in hexanes, 37.7 mmol)
added slowly, after which the reaction was allowed to warm to
room temperature. The solution was then cooled to −78 ◦C and t-
butyldichlorophosphine (2.00 g as a solution in 10 mL diethyl ether,
12.57 mmol) added slowly by dropping funnel. The solution was
then allowed to warm slowly to room temperature. After 16 h the
dark green solution was washed with water. The diethyl ether layer
retained and dried with MgSO4, filtered and the solvent removed.
Recrystalisation from methanol yielded the product as air stable
white crystals (3.880 g, 10.25 mmol) in 82% yield.
The same procedure used in the preparation of 5 was followed.
From 4 (180 mg, 0.62 mmol) the title compound was obtained an
orange solid. Yield: 63 mg (28%). X-ray diffraction: crystals suitable
for X-ray diffraction were grown by slow diffusion of hexane into
a dichloromethane solution of the product at room temperature.
1H NMR (500 MHz, CD2Cl2): ı 8.16 (m, 2H, minor); 8.08 (m,
2H, major), 7.76–7.72 (m, 2H), 7.62–7.53 (m, 4H), 2.57–2.48 (m,
4H), 2.16–2.09 (m, 2H), 1.92–1.85 (m, 2H), 1.56–1.49 (m, 4H),
1.25–1.22 (m, 18H), 1.02 (t, 6H, J = 7.4 Hz, major), 0.98 (t, 6H,
1
J = 7.4 Hz, major). 13C{ H} NMR (125 MHz, CD2Cl2): ı 138.2 (CH,
minor), 137.7 (CH, major), 133.2–132.8 (m, C), 131.0–132.8 (m, C),
130.4 (d, CH, J = 3.7 Hz, minor), 130.4 (d, CH, JCP = 3.7 Hz, major),
123.4 (CH, major), 123.4 (CH, minor), 36.9–36.6 (m, C); 31.0 (s, CH2),
30.8 (s, CH2), 28.6 (s, CH3), 28.1 (s, CH3, 25.4–25.2 (m, CH2), 23.4 (m,
1H NMR (300 MHz; C6D6): ı 7.75 (2 H, d m, J = 7.5 Hz, ArH o-CF3),
7.6 (2H, ddd, J = 5.3 Hz, J = 8 Hz, ArH o-P), 7.4 (2H, td, J = 7.5 Hz, ArH),
7.32 (2H, td, J = 7.5 Hz, ArH), 1.2 (9H, d, J = 13.3, (CH3)3). 1H{31P}
NMR (300 MHz; C6D6): ı 7.75 (2 H, dm, J = 7.5 Hz, ArH o-CF3), 7.6
(2H, dd, J = 8 Hz, ArH o-P), 7.4 (2H, td, J = 7.5 Hz, ArH), 7.32 (2H,
1
CH2), 14.0 (s, CH3). 31P{ H} NMR (202 MHz, CD2Cl2): ı +39.4 (s, br).
19F{ H} NMR (470 MHz, CD2Cl2): ı −53.6 (major, br); −53.7 (minor,
1
1
td, J = 7.5 Hz, ArH), 1.2 (9 H, s, (CH3)3). 13C{ H} NMR (100 MHz;
br). MS (EI):776(M+NH4+), 722(M−Cl). Calcd. forC30H44Cl2F6P2Pd,
CDCl3): ı 136.1 (d, J = 40 Hz, ArCH), 136.0 (s, ArCH), 135.3 (m, ArC-
CF3), 130.5 (s, ArCH), 128.5 (s, ArCH), 127.2 (m, ArCH o-CF3), 124.2
(q, J = 275 Hz, CF3), 31.7 (d, J = 21 Hz, P-C(CH3)3), 29.3 (d, J = 16 Hz,
C 47.54%, H 5.85%; found: C 47.52%, H 5.76%.
2.11. Procedure for hydroxycarbonylation
1
CH3). 19F NMR: ı −55.8 (d, J = 51.1 Hz), 31P{ H} NMR: ı −2.6 (sep,
J = 51.2 Hz), IR (cm−1), KBr, 3050, 2900–3000, 2200, 1300. MS ES+:
m/z 401.02 ([M+Na]+ requires 401.09). Anal. Calcd. for C18H17F6P:
C, 57.15; H, 4.53% found: C, 56.66; H, 4.73%.
A Biotage 2 mL microwave vial containing a stirring bar was
charged with the appropriate amounts of LiCl, para-toluenesulfonic
acid, catalyst and substrate if the latter was a solid. The vial